(19)
(11) EP 2 747 798 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
18.12.2019 Bulletin 2019/51

(45) Mention of the grant of the patent:
30.10.2019 Bulletin 2019/44

(21) Application number: 12828672.1

(22) Date of filing: 27.08.2012
(51) International Patent Classification (IPC): 
A61L 29/10(2006.01)
A61L 31/08(2006.01)
A61M 25/00(2006.01)
 A61L 33/02(2006.01)
B82Y 30/00(2011.01)
(86) International application number:
PCT/US2012/052531
(87) International publication number:
WO 2013/033023 (07.03.2013 Gazette 2013/10)

(54)

BIO-COMPATIBLE CONTAINER

BIOKOMPATIBLER BEHÄLTER

CONTENEUR BIOCOMPATIBLE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 26.08.2011 US 201161528060 P
16.03.2012 US 201213422973

(43) Date of publication of application:
02.07.2014 Bulletin 2014/27

(73) Proprietor: PFM Medical, Inc.
Carlsbad, CA 92008 (US)

(72) Inventor:
  • KERR, Marshall
    Carlsbad, CA 92008 (US)

(74) Representative: London IP Ltd 
100 High street Milford on Sea
Lymington, Hampshire SO41 0QE
Lymington, Hampshire SO41 0QE (GB)


(56) References cited: : 
RU-A- 2008 139 083
US-A- 4 054 139
US-A- 5 770 255
US-A1- 2007 286 942
 RU-A- 2009 125 467
US-A- 5 468 562
US-A1- 2003 050 691
US-A1- 2010 204 777
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).